3Donadio J V, Grande J P. IgA nephropathy[ J]. N Engl J Med, 2002, 347(10) : 738 -748.
4Quackenbush J. Computational analysis of microarray data[ J]. Nat Rev Genet,2001,2(6) :41g -427.
5Cummins J M, He Y, Leary R J, et al. The colorectal microRNAome [J]. Proc Natl Acad Sci U S A, 2006,103(10) : 3687 -3692.
6Smith A C, de-Wolff J F, Molyneux K, et al. O-Glycosylation of serum IgD in IgA nephropathy[J]. J Am Soc Nephrol, 2006, 17(8-) : 1192 - 1199.
7Espinosa M, Ortega R, Gomez-Carrasco J M, et al. Mesangial C4d deposition: a new prognostic factor in IgA nephropathy [ J ]. Ncphrol Dial Transplant, 2008,8( 1 ) :563 -568.
8Suzuki H, Suzuki Y, Yamanaka T,et al. Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22 - 23[J]. J Am Soc Nephrot, 2005, 16(5) : 1289 -1299.
9Praga M, Gutierrez E, Gonzalez E, et al. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial [ J ]. J Am Soc Nephrol, 2003, 14(6) : 1578 - 1583.
10Calin G A, Dumitru C D, Shimizu M, et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia[J]. Proc Natl Acad Sci U S A, 2002, 99(24) : 15524 - 15529.
